Table of Content

1 INTRODUCTION (Page No. - 25)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 GEOGRAPHIC SCOPE
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION FOR JOHNSON & JOHNSON
          FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
          FIGURE 7 MARKET SIZE ESTIMATION FROM PARENT MARKET
           2.2.1 GROWTH FORECAST
                    FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 9 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS
    2.5 STUDY ASSUMPTIONS
    2.6 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 11 SINUS DILATION DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 ENDOSCOPES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 SINUS DILATION DEVICES MARKET OVERVIEW
          FIGURE 17 HIGH PREVALENCE OF CHRONIC SINUSITIS TO DRIVE MARKET
    4.2 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2022–2027
          FIGURE 18 HOSPITALS AND ASCS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.3 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT AND COUNTRY (2022)
          FIGURE 19 BALLOON SINUS DILATION DEVICES SEGMENT TO DOMINATE ASIA PACIFIC MARKET IN 2022
    4.4 GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET
          FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 21 SINUS DILATION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 High prevalence of chronic sinusitis
                    5.2.1.2 Benefits of balloon dilation procedures over traditional endoscopic sinus surgeries
                    5.2.1.3 Growing preference for minimally invasive surgeries
                    5.2.1.4 Rising healthcare expenditure
                                FIGURE 22 CURRENT HEALTH EXPENDITURE PER CAPITA
                    FIGURE 23 CURRENT HEALTH EXPENDITURE (% OF GDP)
                    5.2.1.5 Increasing availability of reimbursements
           5.2.2 RESTRAINTS
                    5.2.2.1 Risks associated with sinus surgeries
                    5.2.2.2 Availability of non-surgical treatments for chronic sinusitis
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare market in emerging economies
                                FIGURE 24 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRIC COUNTRIES, 2012–2019
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled otolaryngologists, ENT surgeons, and endoscopists
                    5.2.4.2 Survival of small players and new entrants
    5.3 RANGES/SCENARIOS
          FIGURE 25 PESSIMISTIC SCENARIO
          FIGURE 26 OPTIMISTIC SCENARIO
          FIGURE 27 REALISTIC SCENARIO
    5.4 VALUE CHAIN ANALYSIS
          FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
    5.5 SUPPLY CHAIN ANALYSIS
          FIGURE 29 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
    5.6 TECHNOLOGY ANALYSIS
          TABLE 2 BENEFITS OF ENDOSCOPIC PROCEDURE
    5.7 PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 INTENSITY OF COMPETITIVE RIVALRY
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 THREAT OF SUBSTITUTES
    5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
                    TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
           5.8.2 BUYING CRITERIA
                    FIGURE 31 KEY BUYING CRITERIA FOR END USERS
                    TABLE 4 KEY BUYING CRITERIA FOR END USERS
    5.9 REGULATORY LANDSCAPE
          TABLE 5 REGULATORY AUTHORITIES GOVERNING SINUS DILATION DEVICES MARKET
    5.10 PATENT ANALYSIS
    5.11 KEY CONFERENCES AND EVENTS
           TABLE 6 LIST OF CONFERENCES AND EVENTS, 2022–2023
    5.12 PRICING ANALYSIS
           TABLE 7 PRICE RANGE FOR SINUS DILATION DEVICES
    5.13 TRADE ANALYSIS
           TABLE 8 NUMBER OF EXPORTS AND IMPORTS RELATED TO ENDOSCOPY EQUIPMENT
    5.14 ECOSYSTEM ANALYSIS
           TABLE 9 ROLE IN ECOSYSTEM
           FIGURE 32 KEY PLAYERS OPERATING IN SINUS DILATION DEVICES MARKET
    5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

6 SINUS DILATION DEVICES MARKET, BY PRODUCT (Page No. - 82)
    6.1 INTRODUCTION
          TABLE 10 SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 BALLOON SINUS DILATION DEVICES
           6.2.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO SUPPORT MARKET
                    TABLE 11 BALLOON SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 ENDOSCOPES
          TABLE 12 ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 13 ENDOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.1 SINUSCOPES
                    6.3.1.1 Largest and fastest-growing segment of endoscopes market
                                TABLE 14 SINUSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 RHINOSCOPES
                    6.3.2.1 Primarily used to examine nasal cavity and passage
                                TABLE 15 RHINOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 SINUS STENTS/IMPLANTS
           6.4.1 SINUS STENTS/IMPLANTS ARE USED POSTOPERATIVELY FOLLOWING AN ENDOSCOPIC SINUS SURGERY
                    TABLE 16 SINUS STENTS/IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.5 HANDHELD INSTRUMENTS
           6.5.1 HANDHELD INSTRUMENTS ARE WIDELY USED IN ALMOST ALL KINDS OF SURGERIES
                    TABLE 17 HANDHELD INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)

7 SINUS DILATION DEVICES MARKET, BY PROCEDURE (Page No. - 90)
    7.1 INTRODUCTION
          TABLE 18 SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
    7.2 STANDALONE SINUS DILATION PROCEDURES
           7.2.1 STANDALONE SINUS DILATION PROCEDURES ARE WIDELY USED FOR SINUS DILATION
                    TABLE 19 STANDALONE SINUS DILATION PROCEDURES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 HYBRID SINUS DILATION PROCEDURES
           7.3.1 HYBRID SINUS DILATION PROCEDURES ARE MORE INVASIVE IN NATURE COMPARED TO STANDALONE PROCEDURES
                    TABLE 20 NUMBER OF SINUS PROCEDURES PERFORMED IN ENGLAND BETWEEN 2010 AND 2019
                    TABLE 21 HYBRID SINUS DILATION PROCEDURES MARKET, BY REGION, 2020–2027 (USD MILLION)

8 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE (Page No. - 94)
    8.1 INTRODUCTION
          TABLE 22 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
    8.2 ADULT PATIENTS
           8.2.1 ADULT PATIENTS DOMINATE MARKET
                    FIGURE 33 THE PERCENTAGE DISTRIBUTION OF CHRONIC SINUSITIS BY AGE GROUP.
                    TABLE 23 ADULT SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.3 PEDIATRIC PATIENTS
           8.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
                    FIGURE 34 TIME OF ONSET OF CRS TO THE FIRST SURGICAL INTERVENTION FOR ENDOSCOPIC SINUS SURGERY PATIENTS.
                    TABLE 24 PEDIATRIC SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

9 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING (Page No. - 99)
    9.1 INTRODUCTION
          TABLE 25 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
    9.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
           9.2.1 LARGEST AND FASTEST-GROWING END USERS OF SINUS DILATION DEVICES
                    TABLE 26 SINUS DILATION DEVICES MARKET FOR HOSPITALS AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)
    9.3 ENT CLINICS
           9.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS ARE SUPPORTING SEGMENT GROWTH
                    TABLE 27 SINUS DILATION DEVICES MARKET FOR ENT CLINICS, BY REGION, 2020–2027 (USD MILLION)

10 SINUS DILATION DEVICES MARKET, BY REGION (Page No. - 102)
     10.1 INTRODUCTION
             TABLE 28 SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 35 NORTH AMERICA: SINUS DILATION DEVICES MARKET SNAPSHOT
             TABLE 29 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 30 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 31 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 32 NORTH AMERICA: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 33 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 34 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Favorable reimbursement scenario for sinus dilation procedures
                                      TABLE 35 US: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 36 US: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 37 US: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
                                      TABLE 38 CANADA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 39 CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 40 CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 41 EUROPE: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 42 EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 43 EUROPE: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 44 EUROPE: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 45 EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 46 EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Rising geriatric population and increasing R&D—key factors driving market
                                      TABLE 47 GERMANY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 48 GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 49 GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Fastest-growing market for sinus dilation devices in Europe
                                      TABLE 50 UK: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 51 UK: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 52 UK: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 High burden of chronic sinusitis to drive market
                                      TABLE 53 FRANCE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 54 FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 55 FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Growing geriatric population to support adoption of sinus dilation devices
                                      TABLE 56 ITALY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 57 ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 58 ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Rising healthcare expenditure to support market for sinus dilation devices
                                      TABLE 59 SPAIN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 60 SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 61 SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 62 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 63 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                        TABLE 64 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 36 ASIA PACIFIC: SINUS DILATION DEVICES MARKET SNAPSHOT
             TABLE 65 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 66 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 67 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 68 ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 69 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 70 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Fastest-growing market for sinus dilation devices
                                      TABLE 71 CHINA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 72 CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 73 CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Large geriatric population to aid market growth
                                      TABLE 74 JAPAN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 75 JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 76 JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 High prevalence of sinusitis will drive demand for sinus dilation devices
                                      TABLE 77 INDIA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 78 INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                                      TABLE 79 INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 80 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 81 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
                        TABLE 82 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
     10.5 REST OF THE WORLD
             TABLE 83 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 84 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
             TABLE 85 REST OF THE WORLD: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 86 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
             TABLE 87 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 131)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             TABLE 88 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINUS DILATION DEVICES MARKET
     11.3 REVENUE SHARE ANALYSIS
             FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINUS DILATION DEVICES MARKET
     11.4 MARKET SHARE ANALYSIS
             TABLE 89 SINUS DILATION DEVICES MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 38 COMPANY EVALUATION QUADRANT: SINUS DILATION DEVICES MARKET
     11.6 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 39 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS: SINUS DILATION DEVICES MARKET
     11.7 COMPANY FOOTPRINT ANALYSIS
             TABLE 90 FOOTPRINT OF COMPANIES IN SINUS DILATION DEVICES MARKET
             TABLE 91 REGIONAL FOOTPRINT OF COMPANIES
             TABLE 92 PRODUCT FOOTPRINT OF COMPANIES
     11.8 COMPETITIVE BENCHMARKING
             TABLE 93 SINUS DILATION DEVICES MARKET: LIST OF KEY STARTUPS/SMES
     11.9 COMPETITIVE SCENARIO
             11.9.1 PRODUCT LAUNCHES/APPROVALS
                        TABLE 94 KEY PRODUCT LAUNCHES
             11.9.2 DEALS
                        TABLE 95 KEY DEALS
             11.9.3 OTHER DEVELOPMENTS
                        TABLE 96 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 148)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 ENTELLUS MEDICAL, INC. (SUBSIDIARY OF STRYKER)
                        TABLE 97 STRYKER: BUSINESS OVERVIEW
                        FIGURE 40 STRYKER: COMPANY SNAPSHOT (2021)
             12.1.2 MEDTRONIC PLC
                        TABLE 98 MEDTRONIC PLC: BUSINESS OVERVIEW
                        FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
             12.1.3 ACCLARENT, INC. (SUBSIDIARY OF JOHNSON & JOHNSON)
                        TABLE 99 JOHNSON & JOHNSON: BUSINESS OVERVIEW
                        FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
             12.1.4 SMITH & NEPHEW PLC
                        TABLE 100 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
                        FIGURE 43 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
             12.1.5 INTERSECT ENT, INC.
                        TABLE 101 INTERSECT ENT, INC.: BUSINESS OVERVIEW
                        FIGURE 44 INTERSECT ENT, INC.: COMPANY SNAPSHOT (2021)
             12.1.6 OLYMPUS CORPORATION
                        TABLE 102 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.7 SINUSYS CORPORATION
                        TABLE 103 SINUSYS CORPORATION: BUSINESS OVERVIEW
             12.1.8 INNACCEL TECHNOLOGIES PVT LTD.
                        TABLE 104 INNACCEL TECHNOLOGIES PVT LTD.: BUSINESS OVERVIEW
             12.1.9 MERIL LIFE SCIENCES PVT. LTD.
                        TABLE 105 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
             12.1.10 OPTIM LLC
                        TABLE 106 OPTIM LLC: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS
             12.2.1 JILIN CORONADO MEDICAL LTD.
                        TABLE 107 JILIN CORONADO MEDICAL LTD.: BUSINESS OVERVIEW
             12.2.2 DALENT MEDICAL
                        TABLE 108 DALENT MEDICAL: BUSINESS OVERVIEW
             12.2.3 EMOS TECHNOLOGY GMBH
                        TABLE 109 EMOS TECHNOLOGY GMBH: BUSINESS OVERVIEW
             12.2.4 SKLAR SURGICAL INSTRUMENTS
                        TABLE 110 SKLAR SURGICAL INSTRUMENTS: BUSINESS OVERVIEW
             12.2.5 KARL STORZ
                        TABLE 111 KARL STORZ: BUSINESS OVERVIEW
             12.2.6 PENTAX MEDICAL
                        TABLE 112 PENTAX MEDICAL: BUSINESS OVERVIEW
             12.2.7 ANGIPLAST PVT. LTD.
                        TABLE 113 ANGIPLAST PVT. LTD.: BUSINESS OVERVIEW
             12.2.8 SUMMIT MEDICAL LLC
                        TABLE 114 SUMMIT MEDICAL LLC: BUSINESS OVERVIEW
             12.2.9 RICHARD WOLF GMBH
                        TABLE 115 RICHARD WOLF GMBH: BUSINESS OVERVIEW
             12.2.10 ENTERMED
                        TABLE 116 ENTERMED: BUSINESS OVERVIEW
             12.2.11 SCHÖLLY FIBEROPTIC GMBH
                        TABLE 117 SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW
             12.2.12 XION GMBH
                        TABLE 118 XION GMBH: BUSINESS OVERVIEW
             12.2.13 COOK MEDICAL
                        TABLE 119 COOK MEDICAL: BUSINESS OVERVIEW
             12.2.14 MAXER ENDOSCOPY GMBH
                        TABLE 120 MAXER ENDOSCOPY GMBH: BUSINESS OVERVIEW
             12.2.15 ESC MEDICAMS
                        TABLE 121 ESC MEDICAMS: BUSINESS OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 192)
     13.1 INDUSTRY INSIGHTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 CUSTOMIZATION OPTIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS